900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Photographer/cameraman NOS	Photographer AND/OR cameraman
Photographer/cameraman NOS	Photographer AND/OR cameraman
Photoptarmosis	Photoptarmosis
Photorhabdus luminescens subspecies thracensis	Photorhabdus temperata subspecies thracensis (organism)
Photosensitising drugs	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.
Phototherapy &/or radiation therapy	Radiotherapy
Phthalic anhydride specific extract	Phthalic anhydride
Phylum Thermomicrobia	Class Thermomicrobia (organism)
Phylum acanthocephala	Phylum Acanthocephala (organism)
Phylum microspora	Phylum Microsporidia (organism)
Physical examination - action	Examination - action
Physical exercise NOS	Physical exercises
Physical exercise NOS	Physical exercises
Physical medicine iontophoresis	An administration into the tissues of an ionic substance by means of an electric current
Physical medicine service	Physical medicine service (qualifier value)
Physical science technician	Physics technician
Physical scientist NOS	Physical scientist (occupation)
Physical scientist NOS	Physical scientist (occupation)
Physical/nutrit. assess NOS	Assessment of nutritional status
Physical/nutrit. assess NOS	Assessment of nutritional status
Physician service	Physician service (qualifier value)
Physics - other therapy	Therapy
Physics - other therapy	Therapy
Physics - other therapy NOS	Therapy
Physics - other therapy NOS	Therapy
Physics-other measurements NOS	Physics - other measurements
Physics-other measurements NOS	Physics - other measurements
Physics: diagn. methods NOS	Determination of a value, conclusion, or inference by evaluating evidence
Physics: diagnostic methods NOS	Determination of a value, conclusion, or inference by evaluating evidence
Physics: other diagn. methods	Determination of a value, conclusion, or inference by evaluating evidence
Physics: other diagnostic methods	Determination of a value, conclusion, or inference by evaluating evidence
Physiol. function test NOS	Physiological function tests
Physiol. function test NOS	Physiological function tests
Physiological functions and activities	Functional status document section (record artifact)
Physiological jaundice (& [NOS])	Newborn physiological jaundice
Physostigmine 0.25% eye drops	Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine 0.5% eye drops	Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.25%+2% eye drops	Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
Physostigmine+pilocarpine 0.25%+4% eye drops	Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.5%+4% eye drops	Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Pichia ohmeri	Kodamaea ohmeri (organism)
Pick's cell	Niemann-Pick cell
Picornavirus	Family Picornaviridae (organism)
Pigeon droppings protein	Pigeon droppings
Pigmented nevus, no International Classification of Diseases for Oncology subtype	Pigmented nevus
Pigmented skin lesion of suspected malignant nature	Malignant pigmented skin lesion suspected
Pigmented villonodular synovitis	Diffuse tenosynovial giant cell tumor
Pigmented villonodular synovitis	Diffuse tenosynovial giant cell tumor
Pigmenting agent	Pigment
Pigmenting agent	Pigment
Pilocarpine hydrochloride 10% eye drops	Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)
Pilocarpine hydrochloride 5.0mg tablet	Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)
Pilocarpine nitrate 1% conventional release eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 1% single-use eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% conventional release eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% single-use eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% conventional release eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocytic astrocytoma	Pilocytic astrocytoma
Pilonidal cyst with no abscess	Pilonidal cyst
Pink color	Pink color (qualifier value)
Pioglitazone 15mg + metformin 1g m/r tablet	Metformin and pioglitazone only product in oral dose form
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet	Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g m/r tablet	Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet	Metformin and pioglitazone only product in oral dose form
Pipe/sheet metal worker NOS	Pipe/sheet/structural metal worker
Pipe/sheet metal worker NOS	Pipe/sheet/structural metal worker
Piperacillin 1g powder for injection solution vial	Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Piperacillin 2g powder for injection solution vial	Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial
Piperacillin 3g injection (pdr for recon)	Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin 4g infusion set	Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperacillin 4g powder for injection solution vial	Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperacillin 4g/tazobactam 500mg powder and solvent for infusion vial	Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Piperacillin sodium + tazobactam sodium ns/ns injection	Product containing piperacillin and tazobactam (medicinal product)
Piperacillin sodium 3g powder for injection solution vial	Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin sodium 4g powder for injection solution vial	Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperazine+sennosides 4g/15.3mg/sachet oral powder	Product containing only piperazine and sennoside (medicinal product)
Piperidolate hydrochloride adverse reaction	Adverse reaction to piperidolate (disorder)
Piple cumanesis cumanesis	Aburria cumanensis subspecies cumanensis (organism)
Pirbuterol acetate 0.2mg aerosol	Product containing only pirbuterol (medicinal product)
Piringer's lymphadenitis	Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome	Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome	Lymphadenitis caused by Toxoplasma gondii (disorder)
Piroxicam 10mg dispersible tablet	Piroxicam 10 mg oral tablet
Piroxicam 20mg conventional release orodispersible tablet	Piroxicam 20 mg oral tablet
Piroxicam 20mg dispersible tablet	Piroxicam 20 mg oral tablet
Piroxicam 20mg melt tablet	Piroxicam 20 mg oral tablet
Pitt Hopkins-like syndrome	A rare genetic syndromic neurodevelopmental disorder with characteristics of moderate to mostly severe intellectual disability, speech impairment with normal or mildly delayed motor development and early-onset seizures often accompanied by developmental regression. Autistic behaviour and stereotypic movements are common. The disorder is caused by bi-allelic intragenic deletions (rarely duplications) or truncating variants in the CNTNAP2 gene (7q35-q36.1). It encodes contactin-associated protein 2 (CASPR2), a transmembrane protein from the neurexin superfamily, which is involved in neural-glia interactions and clustering of potassium channels in myelinated axons. Inheritance is autosomal recessive.
Pituitary adenoma, no International Classification of Diseases for Oncology subtype	Benign pituitary adenoma (morphologic abnormality)
Pituitary hypothyroidism	Secondary hypothyroidism
Pituitary interstitial cell stimulating hormone	Pituitary luteinizing hormone
Pituitary/adrenal hormones NOS	Pituitary/adrenal hormone measurement
Pituitary/adrenal hormones NOS	Pituitary/adrenal hormone measurement
Pityriasis NOS	Pityriasis
Pityriasis NOS	Pityriasis
Pityriasis lichenoides chronica	Chronic lichenoid pityriasis
Pityriasis lichenoides et varioliformis acuta	Acute lichenoid pityriasis
Pityriasis lichenoides et varioliformis of Mucha-Habermann	Acute lichenoid pityriasis
Pityrosporum folliculitis	Malassezia folliculitis (disorder)
Pityrosporum infection of skin	Malassezia infection of skin (disorder)

Start Previous Page 150 of 235 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)